Founder & CEO
Dr. Afsaneh Taheri Kal-Koshvandi - Inventor of Bioluminescence-based Proximity Labeling
Pioneering Synthetic Biology
Dr. Afsaneh Taheri Kal-Koshvandi is the visionary founder and CEO of Lucidix Inc., with extensive expertise in synthetic biology, proximity labeling technologies, and therapeutic development. Her groundbreaking research has led to the invention of Bioluminescence-based Proximity Labeling, a revolutionary technology that eliminates the need for external light sources and enables deep-tissue proteomic interrogation.
With a strong background in molecular biology and biotechnology, Dr. Taheri has dedicated her career to developing novel approaches for precise biological engineering. Her work on light-free proximity labeling systems represents a significant advancement in the field, enabling applications previously not possible with conventional methods.
Under her leadership, Lucidix has rapidly expanded its intellectual property portfolio with 18+ patent families and is positioned to transform multiple therapeutic areas through its modular technology platform.